Article
Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity.
Protein engineering, design & selection : PEDS - 1 Apr 2010
Taylor Noah D, Way Jeffrey C, Silver Pamela A, Cironi Pablo
Abstract excerpt
The presence of erythropoietin (Epo) receptors on cells besides red blood cell precursors, such as cancer cells or megakaryocyte precursors, can lead to side effects during Epo therapy including enhanced tumor growth and platelet production. It would be ideal if the action of Epo could be limited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
